This test is done in the 14th to 18th week of pregnancy. A small amount of the amniotic fluid is taken from the uterus and then sent to a laboratory to be studied. Cells from the developing baby are found in the amniotic fluid.
Neonatal Tests
No anaesthetic is required, and a result is usually obtained in about three to four weeks. When the test is carried out by an obstetrician experienced in the technique, the risk of a miscarriage related to the test is about 1 per cent (occurring in 1 in 100 pregnancies). | Embryo Website | Prenatal Diagnosis
This test must be done in the 10th to 12th week after the first day of the mother's last menstrual period. The test is done by looking at cells taken from the placenta.
Prenatal Tests
No anaesthetic is required, and a test result is usually available in two to three weeks. When the test is carried out by an obstetrician experienced in the technique, the risk of miscarriage related to the test is about 2 per cent (occurring in 1 in 50 pregnancies).
The ultrasound scan uses sound waves to generate images of the fetus and is harmless to the mother and baby. This test can tell the age of the pregnancy and if you are carrying more than one baby. It can also be used to detect abnormalities of infant and placenta.
Prenatal Tests
Also called percutaneous umbilical blood sampling, PUBS, fetal blood sampling, umbilical vein sampling. This chromosome analysis test is done at in the 18th week or later of high-risk pregnancies.
Prenatal Tests
A technique of sampling of extracoelomic fluid usually for an early prenatal diagnostic technique. (Notes under Development)
Prenatal Tests
false negative rate - The proportion of pregnancies that will test negative given that the congenital anomaly is present.
false positive rate - The proportion of pregnancies that will test positive given that the congenital anomaly is absent.
negative predictive value - The probability that a congenital anomaly is absent given that the prenatal screening test is negative.
positive predictive value - The probability that a congenital anomaly is present given that the prenatal screening test is positive.
pre-implantation genetic diagnosis - (PGD) a screening procedure for embryos produced through in vitro fertilisation (IVF) for genetic diseases that would generate developmental abnormalities or serious postnatal diseases.
prenatal screening sensitivity - (detection rate) The probability of testing positive on a prenatal screening test if the congenital anomaly is present.
prenatal screening specificity - The probability of testing negative on a prenatal screening test if the congenital anomaly is absent.
Dr Mark Hill is a senior lecturer in the School of Medical Sciences, The University of New South Wales, Sydney Australia. Email the Author |
|
|
I have been an educator to both Medical and Science students in Embryology and Cell Biology at the University level for the last 13 years. I am interested in how new technologies can be used to best present, and help aid the understanding of, complex developmental processes.
My laboratory research interests are looking at the relationship between cell shape and function, in particular in neurological development and disease. |
|